FIELD: organic chemistry, pharmacy.
SUBSTANCE: invention relates, in particular, to derivatives of phenylalaninol of the formula (I):
wherein X mean group of the formula (X-1): Y means group of the formula (Y-1):
wherein R15 means halogen atom, nitro-group, (lower)-alkyl, perfluoro-(lower)-alkyl; R16 means hydrogen, halogen atom, nitro-group, (lower)-alkyl; R22 and R23 mean independently hydrogen atom, (lower)-alkyl, halogen atom or perfluoro-(lower)-alkyl and at least one radical among radicals R22 and R23 doesn't mean hydrogen atom; R24 means hydrogen atom; or Y means group (y-3) that represents 3-7-membered ring of the formula: wherein R25 means group of the formula R26-(CH2)e- wherein R26 means (lower)-alkoxy-group, (lower)-alkylthio-group, (lower)-alkylsulfonyl, (lower)-alkylsulfinyl; Q means group of the formula -(CH2)f wherein e means a whole number from 0 to 4; f means a whole number from 1 to 3. Also, invention describes a pharmaceutical composition eliciting an anti-inflammatory activity and comprising compounds described above.
EFFECT: valuable medicinal properties of derivatives and composition.
12 cl, 4 ex
Title | Year | Author | Number |
---|---|---|---|
DERIVATIVES OF THIOAMIDE AND PHARMACEUTICAL COMPOSITION | 2000 |
|
RU2245874C2 |
N-ALKANOYLPHENYLALANINE DERIVATIVES | 1998 |
|
RU2220950C2 |
4-PYRIDINYL-N-ACYL-L-PHENYLALANINES | 2000 |
|
RU2270193C2 |
4-PYRIMIDINYL-N-ACYL-L-PHENYLALANINES AND PHARMACEUTICAL COMPOSITION | 2000 |
|
RU2266901C2 |
METHOD FOR TREATMENT OF STATES CAUSED BY p38 KINASES AND PYRROLOTRIAZINE COMPOUNDS USED AS KINASE INHIBITORS | 2001 |
|
RU2316556C2 |
AMINOQUINAZOLINE COMPOUNDS | 2005 |
|
RU2382034C2 |
PHTHALAZINES ELICITING ANGIOGENESIS INHIBITORY ACTIVITY | 1998 |
|
RU2207132C2 |
METHOD FOR PREPARING DERIVATIVES OF 2-AMINO-4-CHLORO-1,3,5-TRIAZINES | 1999 |
|
RU2271353C2 |
METHOD FOR TREATING DIABETES | 2003 |
|
RU2320343C2 |
WOOD PRESERVATION COMPOSITIONS | 1999 |
|
RU2236427C2 |
Authors
Dates
2004-10-20—Published
2000-02-12—Filed